We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

14 hedge funds and large institutions have $3.06M invested in ENDRA Life Sciences in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

27% more funds holding

Funds holding: 11 → 14 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

50% less capital invested

Capital invested by funds: $6.06M → $3.06M (-$3M)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$722K
2
Renaissance Technologies
Renaissance Technologies
New York
+$255K
3
RJA
Raymond James & Associates
Florida
+$84.9K
4
VF
Virtu Financial
New York
+$84.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$42.5K

Top Sellers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
-$61K
2
NA
NewEdge Advisors
Louisiana
-$42.5K
3
SWM
Spire Wealth Management
Virginia
-$17K
4
MPWT
MassMutual Private Wealth & Trust
Connecticut
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.18M – – –
Morgan Stanley
2
Morgan Stanley
New York
$583K +$722K +17 +243%
NA
3
NewEdge Advisors
Louisiana
$462K -$42.5K -1 -5%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$223K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$150K +$255K +6 New
BlackRock
6
BlackRock
New York
$75K – – –
State Street
7
State Street
Massachusetts
$67K – – –
5L
8
55I LLC
Massachusetts
$61K – – –
VF
9
Virtu Financial
New York
$50K +$84.9K +2 New
RJA
10
Raymond James & Associates
Florida
$49K +$84.9K +2 New
Northern Trust
11
Northern Trust
Illinois
$44K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$34K +$42.5K +1 New
Osaic Holdings
13
Osaic Holdings
Arizona
$30K – – –
UBS Group
14
UBS Group
Switzerland
$19K – – –
IC
15
IEQ Capital
California
$12K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$11K – – –
GWM
17
Geneos Wealth Management
Colorado
$1K – – –
National Bank of Canada
18
National Bank of Canada
Quebec, Canada
$1K – – –
Wells Fargo
19
Wells Fargo
California
$1K – – –
William Blair & Company
20
William Blair & Company
Illinois
– -$61K -1 Closed
MPWT
21
MassMutual Private Wealth & Trust
Connecticut
– -$10K – –
SWM
22
Spire Wealth Management
Virginia
– -$17K – –

NDRA Hedge Fund Activity: Q4 2021 in Review

14 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2021, worth a combined $3.06M — down 50% from $6.06M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NDRA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $722K. The largest seller was William Blair & Company, exiting entirely with an estimated $61K sold.

  • 14 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2021, up from 11 in Q3 2021.
  • Funds reported $3.06M of ENDRA Life Sciences stock for Q4 2021, down 50% quarter-over-quarter.
  • 4 funds opened new ENDRA Life Sciences positions in Q4 2021 and 1 closed out, a net change of +3 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2021 was Morgan Stanley, an estimated $722K added.
  • The largest ENDRA Life Sciences seller in Q4 2021 was William Blair & Company, an estimated $61K sold.

Based on aggregated 13F filings for Q4 2021.